aromasil has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, SH; Hwang, O; Lee, JA; Shin, EJ; Son, HJ | 1 |
1 other study(ies) available for aromasil and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Androstadienes; Animals; Antineoplastic Agents; Antiparkinson Agents; Cell Line; Dopaminergic Neurons; Drug Repositioning; Gene Expression Regulation; Heme Oxygenase-1; Hindlimb Suspension; Interleukin-1beta; Lipopolysaccharides; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Microglia; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type II; Parkinsonian Disorders; Reactive Oxygen Species; Rotarod Performance Test; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |